Ian Bilmon
Impact in
- Hematology top 10%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Transplantation top 10%
Papers in
-
- Hematopoietic Stem Cell Transplantation 7
- Acute Myeloid Leukemia Research 4
- Genetics 3
- Mesenchymal stem cell research 2
- Myeloproliferative Neoplasms: Diagnosis and Treatment 1
- Co-authors
- David Gottlieb (8 shared papers)Emily Blyth (6 shared papers)Kenneth Micklethwaite (6 shared papers)Leighton Clancy (2 shared papers)David Bishop (1 shared paper)Ming‐Celine Dubosq (1 shared paper)John Kwan (5 shared papers)Kenneth F. Bradstock (2 shared papers)
- Journals
- Biology of Blood and Marrow Transplantation (2 papers)Cytotherapy (2 papers)Blood (1 paper)Journal of Clinical Oncology (1 paper)Emerging infectious diseases (1 paper)
- Partner nations
- AustraliaNew ZealandUnited States
In The Last Decade
Ian Bilmon
10 papers receiving 214 citations
Peers
Comparison fields: 5 of 42
- Hematology 94
- Transplantation 19
- Oncology 123
- Immunology 54
- Parasitology 13
Countries citing papers authored by Ian Bilmon
This map shows the geographic impact of Ian Bilmon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Bilmon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Bilmon more than expected).
Fields of papers citing papers by Ian Bilmon
This network shows the impact of papers produced by Ian Bilmon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Bilmon. The network helps show where Ian Bilmon may publish in the future.
Co-authors
The 25 scholars most cited alongside Ian Bilmon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 79 | |
| 2 | 2015 | 41 | |
| 3 | 2015 | 29 | |
| 4 | 2012 | 22 | |
| 5 | 2012 | 13 | |
| 6 | 2018 | 13 | |
| 7 | 2022 | 6 | |
| 8 | 2018 | 5 | |
| 9 | 2019 | 3 | |
| 10 | 2020 | 3 | |
| 11 | 2024 | 0 | |
| 12 | 2023 | 0 |
About Ian Bilmon
Ian Bilmon is a scholar working on Hematology, Genetics, Pediatrics, Perinatology and Child Health, Oncology and Immunology, having authored 12 papers that have together received 214 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (7 papers), Acute Myeloid Leukemia Research (4 papers), Childhood Cancer Survivors' Quality of Life (3 papers), Mesenchymal stem cell research (2 papers), T-cell and B-cell Immunology (2 papers), Immune Cell Function and Interaction (2 papers), Cytomegalovirus and herpesvirus research (1 paper) and Myeloproliferative Neoplasms: Diagnosis and Treatment (1 paper). The work is most often cited by research in Hematology (94 citations), Transplantation (19 citations), Oncology (123 citations), Immunology (54 citations) and Parasitology (13 citations). Ian Bilmon has collaborated with scholars based in Australia, New Zealand and United States. Frequent co-authors include David Gottlieb, Emily Blyth, Kenneth Micklethwaite, Leighton Clancy, David Bishop, Ming‐Celine Dubosq, John Kwan, Kenneth F. Bradstock, Val Gebski and Gillian Huang. Their work appears in journals such as Biology of Blood and Marrow Transplantation, Cytotherapy, Blood, Journal of Clinical Oncology and Emerging infectious diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.